Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forearm Nerve Blockade Injection Techniques
NCT03649763Phase 4Completed
- Sponsor
- NYSORA
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine, bupivacaine in carpal tunnel syndrome (CTS), sponsored by NYSORA. Started Mar 2018; status: completed.
02
Drugs
lidocainebupivacaine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT03649763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03649763.